Pharma Journalist -

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced that the Phase 1a solid tumor trial exploring the safety and…
Read More...

Pharmaceutical and biopharmaceutical manufacturers can now verify the identity of ionic salts in the warehouse in a matter of seconds with a new portable X-ray fluorescence (XRF)…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved XARELTO (rivaroxaban) for the prevention of venous…
Read More...

Gilead Sciences, Inc. and Galapagos NV  announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of filgotinib, an investigational, oral, selective JAK1…
Read More...

SMi Reports: A panel discussion has been set for the 12th annual Pre-Filled Syringes and Injectable Drug Devices conference to be held in London on the 15th and 16th January.  The 12th…
Read More...

UCB and Ra Pharmaceuticals Inc. announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma. Under the terms of the agreement, Ra Pharma shareholders…
Read More...

Biocatalysis multinationals such as GlaxoSmithKline plc, AstraZeneca, Givaudan, Roche, Firmenich, and L’Oréal will present at the conference alongside academic innovators, including,…
Read More...

Dermira, Inc. announced that detailed primary results of its Phase 2b study of lebrikizumab in patients with moderate-to-severe atopic dermatitis will be reported at the 39th Annual…
Read More...

Alexion Pharmaceuticals and Stealth BioTherapeutics Corp announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being…
Read More...

Avacta Group plc announces that it has entered a collaboration and option agreement with ADC Therapeutics SA (Lausanne, CH), a clinical-stage oncology-focused biotechnology company…
Read More...